2015 CMHC Preliminary Program Agenda

10th Annual Cardiometabolic Health Congress

Learn Why Attending the Cardiometabolic Health Congress is Important to Your Practice

Co-Chairs Christie M. Ballantyne, MD and Robert H. Eckel, MD discuss how the CMHC provides the most comprehensive CME program addressing the intertwined epidemics of cardiovascular and metabolic diseases, translating the latest science to solutions for front-line clinicians.

Register Now

Wednesday, October 21, 2015

On a mobile device? Drag the schedule to the right to view all the event details.

PRE-CONFERENCE ACTIVITIES
12:30pm - 2:00pm

Lunch Symposium (non-CME)

RepathaTM (evolocumab): Product Overview
Sponsored by Amgen, Inc.
James A. Underberg, MD
2:00pm - 3:15pm

Symposium (non-CME)

Clinical Management of Inflammatory Responses in Vascular Patients
Sponsored by Metagenics
Marlene Grenon, MD
John Troup, PhD
3:15pm - 4:30pm

Symposium (non-CME)

RNA-targeting Antisense Technology Explained
Sponsored by Genzyme, a Sanofi company
Richard S. Geary, PhD
4:30pm - 5:45pm

Symposium (non-CME)

Advancing Knowledge of Hypertriglyceridemia
Sponsored by AstraZeneca
James M. Falko, MD
5:45pm - 7:00pm

Reception Symposium (non-CME)

Strategies for Effective Weight Management
Sponsored by Novo Nordisk, Inc.
Nikhil Dhurandhar

Thursday, October 22, 2015

On a mobile device? Drag the schedule to the right to view all the event details.

6:30am - 8:00am

CME Dialectic Breakfast Symposium A

Current Controversies and Novel Insights into Lipid Management:
The Good, the Bad and the Ugly?
Supported by an educational grant from Lilly
Michael H. Davidson, MD (Chair)
Sergio Fazio, MD;
Robert S. Rosenson, MD
6:45am - 7:45am

CME Expert Roundtable Breakfast Workshop Symposium B

Hypertriglyceridemia - A Neglected CVD Risk Factor:
Getting to the Heart of the Matter
Supported by an educational grant from AstraZeneca
Christie M. Ballantyne, MD (Chair)
Henry N. Ginsberg, MD
Michael Miller, MD
SESSION I: DYSLIPIDEMIA, ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE RISK REDUCTION
8:00am - 8:10am General Sessions Begin: Opening Remarks Christie M. Ballantyne, MD
8:10am - 8:40am

Keynote Session


PCSK9: From Gene to Therapy
Jay D. Horton, MD
8:40am - 9:05am Triglycerides & HDL: Where Are We Now and What's on the Horizon? Henry N. Ginsberg, MD
9:05am - 9:35am IMPROVE-IT: How Do We Go Forward with the Guidelines? Moderator:
Christie M. Ballantyne, MD

Discussants:
Jennifer G. Robinson, MD, MPH
Roger S. Blumenthal, MD
9:35am - 10:00am Integrating Biomarkers and Imaging for CV Risk Assessment and Treatment Matthew J. Budoff, MD
10:00am - 11:00am

Morning Break/Exhibitor Showcase

11:00am - 11:45am Clinical Controversies in Lipid Management: Case-Based Presentations & Discussion Moderator:
Christie M. Ballantyne, MD

Presenters & Discussants:
Roger S. Blumenthal, MD
Robert H. Eckel, MD
Henry N. Ginsberg, MD
Jennifer G. Robinson, MD, MPH
11:45am - 1:45pm

CME Deep Dive Lunch Symposium A

Going Beyond "Eat Less and Move More": Proactive and Progressive Approaches In Obesity Management
Supported by educational grants from Novo Nordisk, Inc. and Takeda Pharmaceuticals U.S.A., Inc.
Robert H. Eckel, MD (Chair)
Harold E. Bays, MD
Samuel Klein, MD
Deborah Bade Horn, DO, MPH
11:45am - 1:45pm

CME Lunch Symposium B

A Closer Look at CV Outcomes for Type 2 Diabetes Therapies: Implications for Patient Care
Supported by an educational grant from Merck & Co., Inc.
Jay S. Skyler, MD (Chair)
Deepak L. Bhatt, MD, MPH
Jennifer B. Green, MD
Darren K. McGuire, MD, MHSc
11:45am - 1:45pm

CME Lunch Symposium C

The Faces of Lipodystrophy: Contemporary Diagnosis and Management Strategies for an Unrecognized Cardiometabolic Disorder
Supported by an educational grant from Aegerion Pharmaceuticals, Inc.

Endorsed by Lipodystrophy United
Abhimanyu Garg, MD (Chair)
Elaine K. Cochran, CRNP
Vinaya Simha, MBBS, MD
Dwanna Swan, PhD
1:45pm - 2:45pm Expert Debates in Antithrombotic Therapy Moderator:
Deepak L. Bhatt, MD, MPH

Presenters & Discussants:
John Eikelboom, MBBS, MSc
A. Michael Lincoff, MD
2:45pm - 3:45pm

Afternoon Break/Exhibitor Showcase

3:45pm - 5:00pm Late-Breaking Clinical Trials and FDA Update Presenters & Discussants:
Christie M. Ballantyne, MD
Deepak L. Bhatt, MD, MPH
Robert H. Eckel, MD
Keith C. Ferdinand, MD
Jay S. Skyler, MD
5:00pm Closing Remarks Christie M. Ballantyne, MD
5:00pm - 6:00pm

Symposium A (non-CME)

Lp-PLA2 Activity Testing: An Advanced New Biomarker for CHD Management
Sponsored by Diadexus, Inc.
Mary Cushman, MD, MSc
Leslie Donato, PhD
Peter McCullough, MD, MPH
Michelle O'Donoghue, MD
5:00pm - 6:00pm

Symposium B (non-CME)

Understanding the Role of VASCEPA® (icosapent ethyl) as Add-on to Statins in Patients With Persistent High Triglyceride Levels (≥200 to <500 mg/dL)
Sponsored by Amarin Pharma
Eliot Brinton, MD
6:00pm - 7:00pm

Welcome Reception/Exhibitor Showcase

7:00pm - 9:00pm

CME Deep Dive Dinner Symposium

Novel Therapies for LDL-C Lowering in the Fight Against Residual ASCVD Risk
Supported by educational grants from Genzyme, a Sanofi company, sanofi-aventis U.S., and Regeneron Pharmaceuticals
Christie M. Ballantyne, MD (Chair)
Jay D. Horton, MD
Patrick M. Moriarty, MD
Jennifer G. Robinson, MD, MPH

Friday, October 23, 2015

On a mobile device? Drag the schedule to the right to view all the event details.

6:30am - 8:00am

CME Breakfast Symposium A

A Conversation with the Experts: New Scientific, Genetic, and Clinical Insights into the Management of Triglycerides
Supported by an educational grant from Amarin Pharma, Inc.
Peter H. Jones, MD (Chair)
Sekar Kathiresan, MD
R. Preston Mason, MBA, PhD
Howard S. Weintraub, MD
6:45am - 7:45am

CME Expert Roundtable Breakfast Workshop Symposium B

Improving CVD Risk Reduction in African Americans: A Call to Action
Supported by an educational grant from Arbor Pharmaceuticals
Clyde W. Yancy, MD, MSc, MACP (Chair)
Keith C. Ferdinand, MD
Gary Puckrein, PhD
SESSION II: HYPERTENSION AND CARDIO-RENAL SYNDROME
8:00am - 8:05am General Sessions Begin: Opening Remarks George L. Bakris, MD
8:05am - 8:30am Management of Resistant Hypertension: An Update George L. Bakris, MD
8:30am - 8:55am Addressing the Unmet Need in Hyperkalemia Treatment Rajiv Agarwal, MD
8:55am - 9:20am Prevention and Treatment of Heart Failure: Novel Therapies Clyde W. Yancy, MD, MSc, MACP
9:20am - 9:45am Diabetes, Kidney Disease and Hypertension Allan J. Collins, MD
9:45am - 10:15am CVD Risk Reduction in Patients with Renal Disease: Cases, Panel Discussion Moderator:
George L. Bakris, MD

Discussants:
Rajiv Agarwal, MD
Allan J. Collins, MD
Clyde W. Yancy, MD, MSc, MACP
10:15am - 11:15am

Morning Break/Exhibit Showcase

SESSION III: LIFESTYLE AND OBESITY MANAGEMENT
11:15am - 11:45am

Keynote Session


Leptin and the Treatment of Obesity and Diabetes
Jeffrey M. Friedman, MD, PhD
11:45am - 1:45pm

CME Lunch Symposium A

The Role of Combination Therapies in Early, Intensive Treatment of Type 2 Diabetes: Patient-Centered Approaches to Improve Glucose Control and Reduce Cardiometabolic Risk Factors
Supported by an educational grant from AstraZeneca
John B. Buse, MD, PhD (Chair)
Lawrence Blonde, MD
Samuel Dagogo-Jack, MD
Carol H. Wysham, MD
11:45am - 1:45pm

CME Lunch Symposium B

New Insights into the Prevention and Clinical Management of Hyperkalemia
Supported by an educational grant from Relypsa, Inc.
George L. Bakris, MD (Chair)
Bertram Pitt, MD
Matthew R. Weir, MD
11:45am - 1:45pm

CME Clinical Advances Spotlight Lunch Symposium C

Advances in LDL Lowering: A Focus on PCSK9 Inhibitors'
Journey from Genetics to Clinical Practice
Supported by an educational grant from Amgen, Inc.
Marc S. Sabatine, MD (Chair)
Seth J. Baum, MD
Michael J. Koren, MD
James A. Underberg, MD
1:45pm - 2:15pm

Keynote Session


The Science Behind Heart Healthy Nutrition and Weight Management
Frank M. Sacks, MD
2:15pm - 2:40pm Pharmacotherapy in the Management of Obesity:
New Drugs and Emerging Targets
Samuel Klein, MD
2:40pm - 3:25pm

Afternoon Break/Exhibit Showcase

3:25pm - 4:05pm Long-Term and Metabolic Effects of Bariatric Surgery Lee M. Kaplan, MD, PhD
Francesco Rubino, MD
4:05pm - 4:30pm Behavior Change: From Compliance to Collaboration Martha M. Funnell, MS, RN, CDE
4:30pm - 5:00pm Obesity & Lifestyle Case Study and Panel Discussion Moderator:
Robert H. Eckel, MD

Discussants:
Martha M. Funnell, MS, RN, CDE
Lee M. Kaplan, MD, PhD
Samuel Klein, MD
Francesco Rubino, MD
Frank M. Sacks, MD
5:00pm Closing Remarks
5:00pm - 6:00pm

10th Annual Celebration/Exhibitor Showcase (Raffle)

6:00pm - 7:00pm

Symposium (non-CME)

Uncovering Generalized Lipodystrophy:
Clinical Characteristics and Treatment Considerations
Sponsored by Aegerion Pharmaceuticals
Tamer Yacoub, MD
Generalized Lipodystrophy Patient Advocate
7:00pm - 9:00pm

CME Dinner Symposium

Paving the Way to Patient Acceptance, Adherence and Satisfaction: The Role of Next-Generation Insulin Therapies
Supported by an educational grant from Novo Nordisk, Inc.
Matthew C. Riddle, MD (Chair)
Anne L. Peters, MD
Martha M. Funnell, MS, RN, CDE
Daniel Einhorn, MD

Saturday, October 24, 2015

On a mobile device? Drag the schedule to the right to view all the event details.

6:30am - 8:00am

CME Breakfast Symposium

The Evolution of Insulin Therapy:
New Developments in Treatment, Technology, and Methods of Administration
Supported by an educational grant from sanofi US
Anne L. Peters, MD (Chair)
Martin J. Abrahamson, MD
Howard A. Wolpert, MD
SESSION IV: DIABETES MANAGEMENT
8:00am - 8:10am General Sessions Begin: Opening Remarks Jay S. Skyler, MD
8:10am - 8:45am Type 2 Diabetes Management Update 2015 Focus on Noninsulin therapies John B. Buse, MD, PhD
8:45am - 9:10am Insulin Therapy: The State-of-the-Science Matthew C. Riddle, MD
9:10am - 9:35am Insulin Resistance and Polycystic Ovary Syndrome: Pathogenesis, Evaluation, and Treatment Andrea E. Dunaif, MD
9:35am - 9:50am

Morning Break

9:50am - 10:15am Advances in Diabetes Technology Anne L. Peters, MD
10:15am - 10:45am

Keynote Session


Insulin and Beta Cell Replacement: From Secretion to Action
Michael R. Rickels, MD, MS
10:45am - 11:45am Diabetes Panel and Cases Moderator:
Jay S. Skyler, MD

Discussants:
John B. Buse, MD, PhD
Andrea E. Dunaif, MD
Anne L. Peters, MD
Michael R. Rickels, MD, MS
Matthew C. Riddle, MD
11:45am Closing Remarks Jay S. Skyler, MD

Note: Agenda & Faculty are subject to change.

Back to 10th Annual CMHC Home